 | BioXcel Therapeutics, Inc. | |||
| NCM : BTAI || Location: United States | ||||
$2.61-0.1 (-3.69%) |
0.66 M | 2.56 - 2.72 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 2.088 M |
| March 28, 2024 | 2.491 M |
| March 15, 2024 | 3.139 M |
| Feb. 29, 2024 | 3.971 M |
| Feb. 15, 2024 | 7.460 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.93 | -0.76 | 18.12% |
| 09/30/2023 | -1.33 | -1.72 | -29.31% |
| 06/30/2023 | -1.79 | -1.83 | -2.47% |
| 03/31/2023 | -1.65 | -1.84 | -11.48% |
| 12/31/2022 | -1.48 | -1.95 | -32.18% |
BTAI Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 30.577M | Shares Float | 23.241M |
| Short Float | 2.088M | Market Cap | 82.86M |
| Institution ownership | 28.50% | Insider ownership | 27.014% |
| Earnings Date | 05/06/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -6.15 | Forward EPS | -1.99 |